Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker MedSurg and Neurotechnology by Quarter
MedSurg and Neurotechnology — Segment Operating Income ($M) ($M)
Stryker MedSurg and Neurotechnology: $1,052M in Q3 2026, down 4.5% from a year earlier.
Latest, Q3 2026
1,052
Period ended Sep 30, 2026
Change on a year earlier
-4.5%
1,102 in Q3 2025
History
23 quarters
Since Q1 2021
Sources
14
Documents cited below
Where the Q3 2026 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker MedSurg and Neurotechnology ($M), quarterly Q1 2021–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/db-seg-ms-opinc
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.